Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed May 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$156K
Net Open-Market Flow
-$156K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Sell(S)52$153.89$8K5K
May 1, 2026Sell(S)288$154.38$44K4K
May 1, 2026Sell(S)346$155.48$54K4K
May 1, 2026Sell(S)82$156.24$13K4K
May 1, 2026Sell(S)106$157.45$17K4K
May 1, 2026Sell(S)65$158.35$10K4K
May 1, 2026Sell(S)38$159.08$6K4K
May 1, 2026Sell(S)23$160.00$4K4K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-204021) within minutes of acceptance. Every field above traces to the original document. Verify it directly: